AdaptHealth (AHCO) Cash from Financing Activities (2018 - 2026)

AdaptHealth's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $52.6 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 193.8% year-over-year to $52.6 million in Q1 2026; TTM through Mar 2026 was -$193.6 million, a 34.66% increase from a year earlier, with the FY2025 full-year figure at -$302.2 million, down 51.89% from the prior year.
• Cash from Financing Activities grew to $52.6 million in Q1 2026 per AHCO's latest filing, from -$32.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $52.6 million in Q1 2026 and bottomed at -$156.6 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is -$32.9 million (2025), against an average of -$35.7 million.
• Biggest YoY gain for Cash from Financing Activities was 828.28% in 2024; the steepest drop was 458.1% in 2024.
• Year by year, Cash from Financing Activities stood at -$15.6 million in 2022, then plunged by 181.32% to -$43.9 million in 2023, then retreated by 23.06% to -$54.0 million in 2024, then soared by 38.98% to -$32.9 million in 2025, then soared by 259.58% to $52.6 million in 2026.
• Per Business Quant, the three latest AHCO Cash from Financing Activities figures stand at $52.6 million (Q1 2026), -$32.9 million (Q4 2025), and -$56.6 million (Q3 2025).